1. Home
  2. RPTX vs GNSS Comparison

RPTX vs GNSS Comparison

Compare RPTX & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPTX
  • GNSS
  • Stock Information
  • Founded
  • RPTX 2016
  • GNSS 1992
  • Country
  • RPTX Canada
  • GNSS United States
  • Employees
  • RPTX N/A
  • GNSS N/A
  • Industry
  • RPTX Biotechnology: Pharmaceutical Preparations
  • GNSS Consumer Electronics/Appliances
  • Sector
  • RPTX Health Care
  • GNSS Consumer Staples
  • Exchange
  • RPTX Nasdaq
  • GNSS Nasdaq
  • Market Cap
  • RPTX 141.1M
  • GNSS 169.5M
  • IPO Year
  • RPTX 2020
  • GNSS N/A
  • Fundamental
  • Price
  • RPTX $1.32
  • GNSS $2.54
  • Analyst Decision
  • RPTX Strong Buy
  • GNSS Strong Buy
  • Analyst Count
  • RPTX 3
  • GNSS 3
  • Target Price
  • RPTX $7.00
  • GNSS $5.33
  • AVG Volume (30 Days)
  • RPTX 664.3K
  • GNSS 175.8K
  • Earning Date
  • RPTX 11-07-2024
  • GNSS 02-11-2025
  • Dividend Yield
  • RPTX N/A
  • GNSS N/A
  • EPS Growth
  • RPTX N/A
  • GNSS N/A
  • EPS
  • RPTX N/A
  • GNSS N/A
  • Revenue
  • RPTX $66,524,000.00
  • GNSS $24,008,000.00
  • Revenue This Year
  • RPTX $13.22
  • GNSS $136.42
  • Revenue Next Year
  • RPTX N/A
  • GNSS $56.53
  • P/E Ratio
  • RPTX N/A
  • GNSS N/A
  • Revenue Growth
  • RPTX 18.19
  • GNSS N/A
  • 52 Week Low
  • RPTX $1.23
  • GNSS $1.51
  • 52 Week High
  • RPTX $8.49
  • GNSS $4.04
  • Technical
  • Relative Strength Index (RSI)
  • RPTX 30.27
  • GNSS 26.74
  • Support Level
  • RPTX $1.23
  • GNSS $2.48
  • Resistance Level
  • RPTX $4.07
  • GNSS $2.88
  • Average True Range (ATR)
  • RPTX 0.34
  • GNSS 0.23
  • MACD
  • RPTX -0.20
  • GNSS -0.11
  • Stochastic Oscillator
  • RPTX 3.34
  • GNSS 9.91

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

About GNSS Genasys Inc.

Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.

Share on Social Networks: